COLDHARBOUR THERAPEUTICS LIMITED
BULMAN HOUSE REGENT CENTRE, GOSFORTH, NEWCASTLE UPON TYNE  NE3 3LS- Active
- Private Limited Company
- Company No. 13352361
- Last Updated: 01 Jun 2023
Company Profile
COLDHARBOUR THERAPEUTICS LIMITED was incorporated on Thursday, April 22, 2021 as a Private Limited Company with registered address in NEWCASTLE UPON TYNE. COLDHARBOUR THERAPEUTICS LIMITED has the status: Active and it's listed in the following category: Research and experimental development on biotechnology. This Private Limited Company has been operating for 3 years 10 months and 2 days.
Name | COLDHARBOUR THERAPEUTICS LIMITED |
---|---|
Company number | 13352361 |
Company type | Private Limited Company |
Incorporation date | 22 Apr 2021 |
Status | Active |
Industry (SIC 2007) |
Address
Registered Address |
BULMAN HOUSE REGENT CENTRE GOSFORTH NEWCASTLE UPON TYNE NE3 3LS |
---|---|
Country Of Origin | UNITED KINGDOM |
Map based on PostCode
Ownership Information
Individuals and organizations with significant control over the business either by owning at least 25% shares or by virtue of significant influence over the business.
Name | Nature of Control |
---|---|
Dr Harry James Bradbury Nationality: British |
Dates: Thursday, April 22, 2021 - present
ownership of shares 25 to 50 percent
voting rights 25 to 50 percent
right to appoint and remove directors
|
Sir Christopher Richard Watkin Edwards Nationality: British |
Dates: Thursday, April 22, 2021 - present
ownership of shares 25 to 50 percent
voting rights 25 to 50 percent
right to appoint and remove directors
|
Accounts and Confirmation
Type of accounts | DORMANT |
---|---|
End of financial Year | 30 April |
Next annual accounts due | 31 January 2024, (-390 days left) |
Latest accounts | 30 April 2022 |
Next confirmation statement due | 20 May 2022 |
Last confirmation statement dated | Not available |
Mortgages
No mortgages have been registered against COLDHARBOUR THERAPEUTICS LIMITED.
Previous Names
Name | Change Date |
---|---|
COLDHARBOUR THERAPEUTICS LIMITED | 22 Apr 2021 |